tradingkey.logo
tradingkey.logo
Search

US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults

ReutersJun 12, 2025 11:32 PM
facebooktwitterlinkedin

- The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's MRNA.O respiratory syncytial virus vaccine to a lower group of high-risk adults aged 18 to 59 years.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI